Date Filed | Type | Description |
02/04/2020 |
4
| Fiorino Anthony S. (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Sold 75,000 shares
@ $0.0035, valued at
$262.5 |
|
11/20/2018 |
3
| Clark John P (See Remarks) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |
05/23/2018 |
4
| Fiorino Anthony S. (Chief Medical Officer and COO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 25,000 shares
@ $0.2391, valued at
$6k
|
|
05/18/2018 |
4
| Fiorino Anthony S. (Chief Medical Officer and COO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 50,000 shares
@ $0.258, valued at
$12.9k
|
|
09/18/2017 |
4
| Fiorino Anthony S. (Chief Medical Officer and COO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 90,000 options
@ $1.1, valued at
$99k
|
|
09/18/2017 |
3
| Fiorino Anthony S. (Chief Medical Officer and COO) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |
07/20/2017 |
4
| Maza Elliot M (Interim CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 100,000 options
@ $2.69, valued at
$269k
|
|
02/03/2017 |
4
| Kimball Ranch C (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
02/03/2017 |
3
| Kimball Ranch C (Director) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |
01/27/2017 |
4
| Paley Jeffrey (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/27/2017 |
4
| Neczesny John A. (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/27/2017 |
4
| Maza Elliot M (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/27/2017 |
4
| Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/27/2017 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/04/2017 |
4
| Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 76,503 shares
@ $0.1859, valued at
$14.2k
|
|
12/20/2016 |
4
| Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
10/11/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
08/19/2016 |
4/A
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
08/04/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
08/04/2016 |
4
| Luchi Monica E. (EVP & CMO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
08/04/2016 |
4
| Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
06/03/2016 |
4
| Ben-Ami Miri (See Remarks) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
06/03/2016 |
4
| Luchi Monica E. (See Remarks) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
06/03/2016 |
4
| Neczesny John A. (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
06/03/2016 |
4
| Militello John (See Remarks) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
06/03/2016 |
4
| Maza Elliot M (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
03/01/2016 |
4
| Paley Jeffrey (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 50,000 options
@ $0.43, valued at
$21.5k
Granted 40,000 options
@ $0.43, valued at
$17.2k
|
|
02/04/2016 |
4
| Neczesny John A. (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 50,000 options
@ $0.52, valued at
$26k
Granted 40,000 options
@ $0.52, valued at
$20.8k
|
|
02/04/2016 |
3
| Neczesny John A. (Director) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |
02/02/2016 |
4
| Maza Elliot M (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 40,000 options
@ $0.53, valued at
$21.2k
|
|
02/02/2016 |
4
| Kazado Daniel (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
02/02/2016 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/26/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
01/19/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC |
|